相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of human rotavirus vaccine on severe diarrhea in African infants
Shabir A. Madhi et al.
MALAWI MEDICAL JOURNAL (2016)
Mucosal Vaccine Design and Delivery
Kim A. Woodrow et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 14 (2012)
Investigation of porcine circovirus contamination in human vaccines
Sarah M. Gilliland et al.
BIOLOGICALS (2012)
Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua
Filemon Bucardo et al.
INFECTION GENETICS AND EVOLUTION (2012)
Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?
Manish M. Patel et al.
LANCET INFECTIOUS DISEASES (2012)
2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis
Jacqueline E. Tate et al.
LANCET INFECTIOUS DISEASES (2012)
VACCINE-DERIVED HUMAN-BOVINE DOUBLE REASSORTANT ROTAVIRUS IN INFANTS WITH ACUTE GASTROENTERITIS
Maria Hemming et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Research priorities regarding rotavirus vaccine and intussusception: A meeting summary
Jacqueline E. Tate et al.
VACCINE (2012)
Rotavirus immune responses and correlates of protection
Juana Angel et al.
CURRENT OPINION IN VIROLOGY (2012)
Genotype constellation and evolution of group A rotaviruses infecting humans
Jelle Matthijnssens et al.
CURRENT OPINION IN VIROLOGY (2012)
Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network
M. Iturriza-Gomara et al.
EPIDEMIOLOGY AND INFECTION (2011)
Rotavirus vaccines Update on global impact and future priorities
Catherine Yen et al.
HUMAN VACCINES (2011)
Rotavirus Vaccine and Health Care Utilization for Diarrhea in US Children
Jennifer E. Cortes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia
J. P. Buttery et al.
VACCINE (2011)
Maternal antibodies to rotavirus: Could they interfere with live rotavirus vaccines in developing countries?
J. Chan et al.
VACCINE (2011)
Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice
Hongli Zhou et al.
VIROLOGY JOURNAL (2011)
An Oral versus Intranasal Prime/Boost Regimen Using Attenuated Human Rotavirus or VP2 and VP6 Virus-Like Particles with Immunostimulating Complexes Influences Protection and Antibody-Secreting Cell Responses to Rotavirus in a Neonatal Gnotobiotic Pig Model
Marli S. P. Azevedo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Rotavirus vaccines for global use What are the remaining issues and challenges?
Baoming Jiang et al.
HUMAN VACCINES (2010)
Performance of rotavirus vaccines in developed and developing countries
Victoria Jiang et al.
HUMAN VACCINES (2010)
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial
K. Zaman et al.
LANCET (2010)
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial
George E. Armah et al.
LANCET (2010)
Vaccine-Acquired Rotavirus in Infants with Severe Combined Immunodeficiency
Niraj C. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Inhibitory Effect of Breast Milk on Infectivity of Live Oral Rotavirus Vaccines
Sung-Sil Moon et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants
Shabir A. Madhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rotaviruses: From Pathogenesis to Vaccination
Harry B. Greenberg et al.
GASTROENTEROLOGY (2009)
Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin
David J. M. Lewis et al.
PLOS ONE (2009)
Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine
Paul E. Makidon et al.
PLOS ONE (2008)
Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice
Claudia Istrate et al.
VACCINE (2008)
Amount of maternal rotavirus-specific antibodies influence the outcome of rotavirus vaccination of newborn mice with virus-like particles
E. Johansson et al.
VACCINE (2008)
Virus-specific intestinal IFN-γ producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs
Lijuan Yuan et al.
VACCINE (2008)
Rotavirus infection is not associated with small intestinal fluid secretion in the adult mouse
Shirin Kordasti et al.
JOURNAL OF VIROLOGY (2006)
Development of the neonatal B and T cell repertoire in swine: implications for comparative and veterinary immunology
JE Butler et al.
VETERINARY RESEARCH (2006)
Immunity and correlates of protection for rotavirus vaccines
MA Franco et al.
VACCINE (2006)
High Titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen
TV Nguyen et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine
TV Nguyen et al.
VACCINE (2006)
Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection
N Parez et al.
JOURNAL OF VIROLOGY (2006)
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis
GM Ruiz-Palacios et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine
T Vesikari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Viremia and nasal and rectal shedding of rotavirus in gnotobiotic pigs inoculated with Wa human rotavirus
AS Azevedo et al.
JOURNAL OF VIROLOGY (2005)
CD4+CD8+double positive (DP) T cells in health and disease
Y Parel et al.
AUTOIMMUNITY REVIEWS (2004)
Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland
M Mutsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines
M Vajdy et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Rotavirus antigenaemia and viraemia:: a common event?
SE Blutt et al.
LANCET (2003)
Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice
A Bertolotti-Ciarlet et al.
VACCINE (2003)
Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs
TV Nguyen et al.
VACCINE (2003)
New generation of mucosal adjuvants for the induction of protective immunity
Y Yuki et al.
REVIEWS IN MEDICAL VIROLOGY (2003)
HIV mucosal vaccine: Nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses
G Sakaue et al.
JOURNAL OF IMMUNOLOGY (2003)
Detection and characterization of pestivirus contaminations in human live viral vaccines
E Studer et al.
BIOLOGICALS (2002)
Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model
LJ Yuan et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2002)
Identification of rotavirus VP6 residues located at the interface with VP2 that are essential for capsid assembly and transcriptase activity
A Charpilienne et al.
JOURNAL OF VIROLOGY (2002)
Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins
I Schwartz-Cornil et al.
JOURNAL OF VIROLOGY (2002)
Frequencies of virus-specific CD4+ and CD8+ T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults
MC Jaimes et al.
JOURNAL OF VIROLOGY (2002)
Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like-particles associated with immuno stimulating complexes
C Iosef et al.
VACCINE (2002)
Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines
Y Kim et al.
VACCINE (2002)
CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G)
MM McNeal et al.
JOURNAL OF VIROLOGY (2002)
Group A rotavirus infection and age-dependent diarrheal disease in rats: A new animal model to study the pathophysiology of rotavirus infection
M Ciarlet et al.
JOURNAL OF VIROLOGY (2002)
Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development
J Kunisawa et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response
C Fromantin et al.
JOURNAL OF VIROLOGY (2001)
Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs
LJ Yuan et al.
JOURNAL OF VIROLOGY (2001)
Intussusception among infants given an oral rotavirus vaccine.
TV Murphy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity
PN Boyaka et al.
JOURNAL OF IMMUNOLOGY (2001)
Serum antibody as a marker of protection against natural rotavirus infection and disease
FR Velázquez et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs
LJ Yuan et al.
JOURNAL OF VIROLOGY (2000)
Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea
A Coste et al.
JOURNAL OF VIROLOGY (2000)
Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration
JR Baldridge et al.
VACCINE (2000)
Immune components in porcine mammary secretions
EA Wagstrom et al.
VIRAL IMMUNOLOGY (2000)
分享论文
